- April 29, 2024
-
-
Loading
Loading
Event Chair Eileen Curd and Keynote Speaker Dr. Brian Czerniecki
Photo by Lori SaxElle McComb and Lauren Dixon
Photo by Lori SaxMoffitt Founder H. Lee Moffitt and Dianne Moffitt with Dennis and Graci McGillicuddy
Photo by Lori SaxJenna Didiego, Erica Didiego, Rachael Cavaliere and Hannah Starr
Photo by Lori SaxDana and Greg Gliniecki
Photo by Lori SaxLaurel Corriveau, A.J. Janson and Christine Robinson
Photo by Lori SaxAmanda Hollis is the director of foundation, corporate and community giving for Moffitt Cancer Center.
Photo by Lori SaxClara Reynardus de Villanueva, Shirley LaSalle and Penny Hill
Photo by Lori SaxAli Givens, Anne Tinker, Mary Blake and Janet Caramello
Photo by Lori SaxFlora Major and Ellen Berman
Photo by Lori SaxSuzanne Reiman, Katie Moulton and Molly Biter
Photo by Lori SaxBeth Bobb and Melissa Long
Photo by Lori Sax
Christine Brown, Rhonda Zemil and Yoli Rodriguez
Photo by Lori SaxMelody Sofi
Photo by Lori SaxMark Ketterer, Tiffany Hughes and David Curry
Photo by Lori SaxHollie Mowry and Amber Lamerson
Photo by Lori SaxEvent Chair Eileen Curd
Photo by Lori SaxLaura Lobdell
Photo by Lori SaxKeynote Speaker Dr. Brian Czerniecki
Photo by Lori SaxLive auctioneer Michael Klauber
Photo by Lori SaxA cancer diagnosis that was once seen as a death sentence has now turned into an opportunity for hope, according to the keynote speaker at the Moffitt Cancer Center's Mission Possible luncheon.
Dr. Brian Czerniecki, department chair of breast oncology at Moffitt, shared how new therapies to treat cancer are giving more patients more hope and better outcomes than ever before. About 250 guests in attendance at the luncheon April 4 at Michael’s On the Bay at Marie Selby Botanical Gardens learned about this research.
The advances are just part of the progress Moffitt Cancer Center Foundation is making in treating the disease since establishing its Research Innovation Fund in 2020. The fund provides seed funding for projects and key research initiatives at the center, including clinical trials and new treatments. Funds raised at the luncheon benefit the fund.
